<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04903600</url>
  </required_header>
  <id_info>
    <org_study_id>CS2-21043</org_study_id>
    <nct_id>NCT04903600</nct_id>
  </id_info>
  <brief_title>Efficacy Assessment of Probiotics Product on Intestinal Health and Immune System Improvement</brief_title>
  <official_title>Efficacy Assessment of Probiotics Fruit Vegetable Fiber Powder on Intestinal Health and Immune System Improvement in Human Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chung Shan Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TCI Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Chung Shan Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effects of probiotics product (probiotics fruit&#xD;
      vegetable fiber powder) on intestinal health and immune system improvement in adults&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This 12 weeks randomized, single-blind and placebo-controlled study will be conduct in fifty&#xD;
      adults. Subjects will be recruited and assigned into two groups in a 1:1 ratio (placebo, n =&#xD;
      25; probiotics, n=25). During the 12 weeks intervention, the subjects should take 32 g powder&#xD;
      of placebo or probiotics product (eat 16 g for once, and twice a day). The two powder&#xD;
      supplied in an aluminum sachet, and all products were identical in taste. Subjects also&#xD;
      should complete the assessment of anthropometric measurement, health conditions, food record,&#xD;
      and sample collection (feces and blood) at week 0, 4, 8 and week 12.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline serum TNF-α at week 12</measure>
    <time_frame>Week0, Week12</time_frame>
    <description>Compared the difference of serum cytokine TNF-α level between the week 12 and 0</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline serum IL-6 at week 12</measure>
    <time_frame>Week0, Week12</time_frame>
    <description>Compared the difference of serum IL-6 level between the week 12 and 0</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline serum IL-10 at week 12</measure>
    <time_frame>Week0, Week12</time_frame>
    <description>Compared the difference of serum IL-10 level between the week 12 and 0</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>32g probiotics fruit vegetable fiber powder product contained 1.12*10(11) CFU of probiotics for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>32g placebo contained only maltodextrin (100%) for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics fruit vegetable fiber powder product</intervention_name>
    <description>Eat 16 g for once, and twice a day</description>
    <arm_group_label>Probiotics</arm_group_label>
    <other_name>Probiotics</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Eat 16 g for once, and twice a day</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inclusion criteria include male or female participants to be aged 20-60 years old, who&#xD;
             had colds more than four times in the past year or had gastric Infection by&#xD;
             Helicobacter pylori or peptic ulcer, body mass index within a healthy range (18.5-27&#xD;
             kg/m2) and willing to commit throughout the experiment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion criteria included cancer, chronic heart disease, use drugs which&#xD;
             pharmacological effects may affect immunity, have systemic infections, use probiotics,&#xD;
             prebiotics, fruit vegetable fiber supplementation, and lactose Intolerance or cow's&#xD;
             milk allergic. Individuals who, in opinion of the investigator, seemed unlikely to&#xD;
             complete the trial were also excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu-Jou Chien, PhD Student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung Shan Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ying-Chi Chen, MS Student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung Shan Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chin-Lin Hsu, Professor</last_name>
    <phone>04-24730022</phone>
    <phone_ext>12222</phone_ext>
    <email>clhsu@csmu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chung Shan Medical University</name>
      <address>
        <city>Taichung</city>
        <state>South</state>
        <zip>402</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chin-Lin Hsu, Professor</last_name>
      <phone>04-24730022</phone>
      <phone_ext>12222</phone_ext>
      <email>clhsu@csmu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 23, 2021</study_first_submitted>
  <study_first_submitted_qc>May 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2021</study_first_posted>
  <last_update_submitted>September 12, 2021</last_update_submitted>
  <last_update_submitted_qc>September 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chung Shan Medical University</investigator_affiliation>
    <investigator_full_name>Chin-Lin Hsu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

